Insider Selling: Cell Therapeutics CEO Sells 130,551 Shares of Stock (CTIC)
Cell Therapeutics (NASDAQ:CTIC) CEO James Bianco unloaded 130,551 shares of the company’s stock in a transaction that occurred on Monday, September 23rd. The shares were sold at an average price of $1.50, for a total transaction of $195,826.50. Following the completion of the sale, the chief executive officer now directly owns 1,483,797 shares of the company’s stock, valued at approximately $2,225,696. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Shares of Cell Therapeutics (NASDAQ:CTIC) traded up 6.88% during mid-day trading on Wednesday, hitting $1.71. The stock had a trading volume of 6,379,180 shares. Cell Therapeutics has a one year low of $0.97 and a one year high of $2.75. The stock has a 50-day moving average of $1.18 and a 200-day moving average of $1.16. The company’s market cap is $184.2 million.
Cell Therapeutics, Inc develops, acquires and commercializes treatments for cancer. It focuses on building a biopharmaceutical company with a diversified portfolio of oncology drugs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.